CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types

Xinlong Zheng(Fujian Medical University), Gen Lin(Fujian Medical University)
Frontiers in Immunology
November 9, 2022
Cited by 17


Related Papers